An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

Journal of Clinical Investigation

Volumn 106, Issue 11, 2000, Pages 1351-1359

  Fatkin, Diane ^a   McConnell, Bradley K ^a   Mudd, James O ^a,b   Semsarian, Christopher ^a   Moskowitz, Ivan G P ^c   Schoen, Frederick J ^c   Giewat, Michael ^a   Seidman, Christine E ^a,c   Seidman, J G ^a,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM; MUSCLE PROTEIN; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL GROWTH; CONTROLLED STUDY; DISEASE COURSE; DYSPNEA; FAMILIAL DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HISTOPATHOLOGY; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMERE; SUDDEN DEATH;

EID: 0033653534     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11093     Document Type: Article

References (43)

1. Prevalence o f hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study
2. Pathophysiology of heart failure
3. Why is left ventricular hyper trophy so predictive of morbidity and mortality?
4. Hypertrophic cardiomyopathy
5. Molecular and cellular biology of cardiac hypertrophy and failure
6. Tissue-specific regulation of the alphamyosin heavy chain gene promoter in transgenic mice
7. Cardiac physiology in transgenic mice
8. Overexpression of Gs alpha protein in the hearts of transgenic mice
9. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
10. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy
11. Meeting Koch's postulates for calcium signaling in cardiac hypertrophy
12. A mouse model of familial hypertrophic cardiomyopathy
13. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1
14. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation
15. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
16. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes
17. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
18. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition
19. Mechanisms of hypertension in cardiac transplantation and the role ofcyclosporine
20. Structural and functional consequences of minoxidil-induced cardiac hypertrophy
21. Changes in left ventricular mass during treatment with minoxidil and cilazapril in hypertensive patients with left ventricular hypertrophy
22. Minoxidil-induced cardiac hypertrophy in guinea pigs
23. A noninvasive computerized tail-cuff system for measuring blood pressure in mice
24. Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates
25. Cyclosporin A induces a biphasic increase in KCl-induced calcium influx in GH3 pituitary cells
26. Cyclosporin A inhibits inositol 1,4,5-trisphosphate binding to its receptors and release of calcium from intracellular stores in peritoneal macrophages
27. Therapeutic options in minimizing left ventricular hypertrophy
28. Cardioprotective effects of diltiazem during acute rejection on heterotopic heart transplants
29. Calcium-antagonist drugs
30. Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine
31. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action
32. Expression of a mutant (Arg92G1n) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility
33. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice
34. Calcineurin inhibitors and cardiac hypertrophy
35. Excitation-contraction coupling in rat heart: Influence of cyclosporin A
36. 2+ flux
37. Cations and anions as modifiers of ryanodine binding to the skeletal muscle calcium release channel
38. 2+release channel function
39. Targeted ablation of the murine alphatropomyosin gene
40. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation
41. Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin
42. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy
43. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy